The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.

The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.

Adenovirus vaccine vectors generated from new viral serotypes are routinely screened in pre-clinical laboratory animal models to identify the most immunogenic and efficacious candidates for further evaluation in clinical human and veterinary settings. Here, we show that studies in a laboratory speci...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Dicks, M, Guzman, E, Spencer, A, Gilbert, S, Charleston, B, Hill, A, Cottingham, M
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	Elsevier 2015

समान संसाधन

Uncovering the mechanisms of adenovirus vector immunogenicity
द्वारा: Dicks, M, और अन्य
प्रकाशित: (2013)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
द्वारा: Dicks, M, और अन्य
प्रकाशित: (2012)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
द्वारा: Dicks, M, और अन्य
प्रकाशित: (2015)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
द्वारा: Matthew D J Dicks, और अन्य
प्रकाशित: (2012-01-01)

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
द्वारा: Warimwe, G, और अन्य
प्रकाशित: (2013)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
द्वारा: Dicks, M, और अन्य
प्रकाशित: (2011)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors.
द्वारा: Cottingham, MG, और अन्य
प्रकाशित: (2012)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors
द्वारा: Cottingham, MG, और अन्य
प्रकाशित: (2011)

Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy.
द्वारा: Dudareva, M, और अन्य
प्रकाशित: (2009)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
द्वारा: Ewer (nee Russell), K, और अन्य
प्रकाशित: (2017)

Novel adenovirus vaccine vectors
द्वारा: Dicks, M
प्रकाशित: (2013)

Chimpanzee adenovirus vaccine provides multispecies protection against Rift Valley Fever
द्वारा: Warimwe, G, और अन्य
प्रकाशित: (2016)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
द्वारा: Katie Ewer, और अन्य
प्रकाशित: (2017-12-01)

Simian adenoviruses as vaccine vectors
द्वारा: Morris, S, और अन्य
प्रकाशित: (2016)

Simian adenoviruses as vaccine vectors
द्वारा: Morris, S, और अन्य
प्रकाशित: (2016)

Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
द्वारा: Catherine Collignon, और अन्य
प्रकाशित: (2020-11-01)

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.
द्वारा: Green, C, और अन्य
प्रकाशित: (2015)

Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
द्वारा: Adam Berg, और अन्य
प्रकाशित: (2021-10-01)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
द्वारा: Biswas, S, और अन्य
प्रकाशित: (2011)

A monovalent chimpanzee adenovirus Ebola vaccine — preliminary report
द्वारा: Rampling, T, और अन्य
प्रकाशित: (2015)

Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs
द्वारा: Joe, CCD, और अन्य
प्रकाशित: (2021)

A monovalent chimpanzee adenovirus ebola vaccine boosted with MVA
द्वारा: Ewer (nee Russell), K, और अन्य
प्रकाशित: (2016)

T cells induced by recombinant chimpanzee adenovirus alone and in prime-boost regimens decrease chimeric EcoHIV/NDK challenge virus load.
द्वारा: Roshorm, Y, और अन्य
प्रकाशित: (2012)

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults
द्वारा: Green, C, और अन्य
प्रकाशित: (2023)

Chimpanzee Adenovirus Antibodies in Humans, Sub-Saharan Africa
द्वारा: Zhiquan Xiang, और अन्य
प्रकाशित: (2006-10-01)

Correlates of Protection Against SIVmac251 Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors
द्वारा: Steven Tuyishime, और अन्य
प्रकाशित: (2018-05-01)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity.
द्वारा: Reyes-Sandoval, A, और अन्य
प्रकाशित: (2012)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity
द्वारा: Reyes-Sandoval, A, और अन्य
प्रकाशित: (2012)

Immune Thrombocytopenia Induced by the Chimpanzee Adenovirus-Vectored Vaccine against SARS-CoV-2 Infection
द्वारा: Po-Wei Liao, और अन्य
प्रकाशित: (2021-12-01)

Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors.
द्वारा: Nébié, I, और अन्य
प्रकाशित: (2014)

A lyophilised formulation of chimpanzee adenovirus vector for long-term stability outside the deep-freeze cold chain
द्वारा: Frédéric Mathot, और अन्य
प्रकाशित: (2025-01-01)

Both chimpanzee adenovirus-vectored and DNA vaccines induced long-term immunity against Nipah virus infection
द्वारा: Mingqing Lu, और अन्य
प्रकाशित: (2023-11-01)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
द्वारा: Antrobus, R, और अन्य
प्रकाशित: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
द्वारा: Antrobus, R, और अन्य
प्रकाशित: (2014)

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
द्वारा: Ewer, K, और अन्य
प्रकाशित: (2013)

Lichenoid drug reaction post-COVID vaccination with the modified chimpanzee adenovirus
द्वारा: Paola Garcia-Mendoza, और अन्य
प्रकाशित: (2022-01-01)

Cytokine Responses to Adenovirus and Adenovirus Vectors
द्वारा: Svetlana Atasheva, और अन्य
प्रकाशित: (2022-04-01)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
द्वारा: Sumi Biswas, और अन्य
प्रकाशित: (2011-01-01)

Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients
द्वारा: Hua Zhao, और अन्य
प्रकाशित: (2018-03-01)

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
द्वारा: Stylianou, E, और अन्य
प्रकाशित: (2015)